OPERATING ACTIVITIES: | |
Net income | -138.04M |
Adjustments to reconcile net income to net cash used in operating activities: | |
Share-based compensation costs | 7.16M |
Depreciation | 38.21M |
Amortization of intangible assets | 22.15M |
Amortization of debt issuance costs | 2.93M |
Deferred income taxes | 662K |
Uncertain tax positions | 610K |
Excess tax benefit from share-based compensation | |
Gain on disposal of property, plant and equipment | -2.48M |
Provision for doubtful accounts | 299K |
Other | |
Changes in operating assets and liabilities: | |
Increase in trade receivables | 28.43M |
Increase in other assets | |
Increase in trade payables | 2.69M |
(Decrease)/ Increase in accrued liabilities and other liabilities | -10.82M |
Net cash used in operating activities | |
INVESTING ACTIVITIES: | |
Purchases of property, plant and equipment | -17.32M |
Proceeds from disposal of property, plant and equipment | 4.16M |
Purchases of software and other intangible assets | |
Net increase in other non-current assets | |
Acquisitions and related payments | |
Other | |
Net cash used in investing activities | |
FINANCING ACTIVITIES: | |
Borrowings from bank lines of credit | |
Repayments of bank lines of credit | |
Net (repayments)/borrowings under revolving lines of credit | 3.68M |
Net (decrease)/increase in short-term borrowings | -9.4M |
Proceeds from issuance of long-term borrowings | 0 |
Repayment of long-term borrowings | -5.32M |
Debt issuance costs | |
Repayment of capital lease obligations | -9.45M |
Contingent consideration paid | |
Acquisition of noncontrolling interest | |
Dividends paid to noncontrolling interests | |
Ordinary shares settled under share based compensation plans | |
Proceeds from issuance of ordinary shares | 179K |
Excess tax benefit from share-based compensation | |
Dividends paid | |
Net cash provided by financing activities | |
Effect of foreign exchange rate changes on cash and cash equivalents | -18.92M |
Net (decrease)/increase in cash and cash equivalents | 53.04M |
Cash and cash equivalents at beginning of period | 211.83M |
Cash and cash equivalents at end of period | 264.87M |